These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19778313)

  • 1. Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus.
    Pahk R; Azu MC; Taira BR; Sandoval S
    Clin Exp Dermatol; 2009 Dec; 34(8):e775-7. PubMed ID: 19778313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.
    Kannenberg SM; Jordaan HF; Koegelenberg CF; Von Groote-Bidlingmaier F; Visser WI
    QJM; 2012 Sep; 105(9):839-46. PubMed ID: 22543685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
    Tartarone A; Lerose R
    Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
    Worswick S; Cotliar J
    Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
    Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal toxic epidermal necrolysis associated with minoxidil.
    Karaoui LR; Chahine-Chakhtoura C
    Pharmacotherapy; 2009 Apr; 29(4):460-7. PubMed ID: 19323621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
    Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.